US Pharmacopeia signs international agreements
This article was originally published in SRA
As part of its efforts to improve the quality of medicines worldwide, the US Pharmacopeial Convention has entered into agreements with a number of international partners, including China, Russia and nine countries belonging to the Association of Southeast Asian Nations.
You may also be interested in...
A new pre-assessment service for COVID-19 clinical trials that was established by the UK medicines regulator to cut down on review times is being extended to a limited number of other kinds of trials.
The European Medicines Agency is developing a strategy to ensure that women have sufficient information to make informed choices about taking medicines during pregnancy and breastfeeding.
A first-of-its-kind collaborative study has found that real-world and natural history data are comparable to placebo data from clinical trials in Duchenne muscular dystrophy.